Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Ovarian Cancer Clinical Trials in Phoenix | 138 Studies

Clinical Trials Ovarian CancerPhoenix

Ovarian Cancer Clinical Trials in Phoenix

Find 138 clinical trials for ovarian cancer near Phoenix, Arizona. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 138 trials

CompletedA Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)The purpose of this phase 3, randomized, multicenter study is to compare VB-111 and paclitaxel to placebo and paclitaxel in adult patients with Recurrent Platinum-Resistant…NCT03398655·Birmingham, Alabama and 93 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPatient Reported Symptoms in Ovarian Cancer (PRECISION)This multicenter, observational, prospective study will include approximately 20 US-based centers, and approximately 142 patients diagnosed with epithelial ovarian cancer, primary…NCT01422265·Goodyear, Arizona and 30 others

Active not recruitingOregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking SurgeryStudy to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemotherapy regimen (paclitaxel…NCT04498117·Phoenix, Arizona and 147 others

UnknownDiet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis randomized phase III trial studies whether changes in diet and physical activity can increase the length of survival without the return of cancer (progression-free survival)…NCT00719303·Birmingham, Alabama and 686 others

WithdrawnA Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian CancerThis is an open label, multi-center, Phase 1/2 clinical trial in subjects with recurrent adenocarcinoma of the ovary who have been previously treated with a minimum of two courses…NCT03281681·Phoenix, Arizona and 2 others

TerminatedAlpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation DetectedThe objective of this study was to assess the efficacy and safety of the combination of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with…NCT04729387·Phoenix, Arizona and 92 others

CompletedComprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing SurgeryThis research trial studies comprehensive patient questionnaires in predicting complications in older patients with gynecologic cancer undergoing surgery.NCT02315469·Birmingham, Alabama and 392 others

CompletedCombination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002568·Birmingham, Alabama and 54 others

CompletedNiraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian CancerThis Phase 1/2 study will evaluate the safety and efficacy of combination treatment with niraparib and pembrolizumab (MK-3475) in patients with advanced or metastatic…NCT02657889·Birmingham, Alabama and 29 others

TerminatedFOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian CancerThis is a multicenter, multinational, randomized, double-blind, 2-arm, parallel-group, Phase 2/3 study to evaluate the efficacy and safety of PCC plus bevacizumab and CA4P versus…NCT02641639·Birmingham, Alabama and 39 others

CompletedCabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis phase II trial studies how well cabozantinib-s-malate works in treating patients with ovarian, fallopian tube, or primary peritoneal cavity cancer that has come back or is…NCT02315430·Anchorage, Alaska and 409 others

CompletedNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersThis phase I trial studies the side effects and best dose of nab-paclitaxel and bevacizumab in treating patients with stage IV melanoma that cannot be removed by surgery…NCT02020707·Phoenix, Arizona and 3 others

Active not recruitingComparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic AgentsThis phase II trial studies the possible benefits of treatment with different combinations of the drugs durvalumab, olaparib and cediranib vs. the usual treatment in patients with…NCT04739800·Anchorage, Alaska and 390 others

CompletedOlaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast CancerThis phase I trial studies the side effects and best dose of olaparib and onalespib when given together in treating patients with solid tumors that have spread to other places in…NCT02898207·Phoenix, Arizona and 7 others

CompletedFirst-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid TumorsTP-0903 is a novel oral inhibitor that targets AXL kinase and reverses the mesenchymal phenotype associated with advanced cancers.NCT02729298·Phoenix, Arizona and 15 others

UnknownIntravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid TumorsA Phase 1/2a Open-Label Dose Escalation and Dose Expansion Study of T3011 when Administered Intravenously as a Single Agent and in Combination with Other Therapy in Subjects with…NCT04780217·Phoenix, Arizona and 5 others

CompletedVTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal CancerThe purpose of this study is to compare the overall survival of patients treated with VTX-2337 + pegylated liposomal doxorubicin (PLD) versus those treated with PLD alone in women…NCT01666444·Phoenix, Arizona and 135 others

TerminatedAn Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian CancerThe study is being conducted to find out if paclitaxel works better when given together with an experimental drug called MORAb-003 (farletuzumab) or alone in patients with…NCT00738699·Mobile, Alabama and 60 others

RecruitingGleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)This Phase 3 study is designed to investigate the safety, diagnostic performance, and clinical usefulness of Gleolan for the real-time detection and visualization of epithelial…NCT05804370·Phoenix, Arizona and 10 others

CompletedPaclitaxel in Treating Patients With Ovarian Stromal CancerThis phase II trial studies the effectiveness of paclitaxel in treating patients who have ovarian stromal cancer.NCT00006227·Birmingham, Alabama and 97 others

PreviousPage 3 of 7Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia